{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:42:00Z","timestamp":1791690120710,"version":"4.3.4"},"reference-count":141,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["111326"],"award-info":[{"award-number":["111326"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.A011.11"],"award-info":[{"award-number":["G.A011.11"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Olivia Hendrickx Research fund"},{"name":"James E. Kearney Foundation"},{"name":"Herman Memorial Research Fund"},{"name":"Belgian Brain Tumor Support, individual donors"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2015.00663","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T12:12:34Z","timestamp":1452773554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines"],"prefix":"10.3389","volume":"6","author":[{"given":"Lien","family":"Vandenberk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Belmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Van Woensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan W.","family":"Van Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"issue":"8","key":"B1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"B2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"issue":"9948","key":"B3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","article-title":"Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial","volume":"384","author":"Robert","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"B4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00262-011-1172-6","article-title":"An immune-active tumor microenvironment favors clinical response to ipilimumab","volume":"61","author":"Ji","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"B6","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"B7","doi-asserted-by":"publisher","first-page":"e107173","DOI":"10.1371\/journal.pone.0107173","article-title":"Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"B8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1755-148X.2010.00736.x","article-title":"Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters","volume":"23","author":"Nakai","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"B9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"B10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.20132","article-title":"Immunotherapy of cancer in 2012","volume":"62","author":"Kirkwood","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"B11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djs033","article-title":"Therapeutic cancer vaccines: current status and moving forward","volume":"104","author":"Schlom","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 7","key":"B12","doi-asserted-by":"publisher","first-page":"vii241","DOI":"10.1093\/annonc\/mdn459","article-title":"Overcoming immunosuppressive mechanisms","volume":"19","author":"Widen","year":"2008","journal-title":"Ann Oncol"},{"issue":"1","key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/imt.09.43","article-title":"Directing dendritic cell immunotherapy towards successful cancer treatment","volume":"2","author":"Sabado","year":"2010","journal-title":"Immunotherapy"},{"issue":"17","key":"B14","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1158\/1078-0432.CCR-13-1185","article-title":"A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside","volume":"19","author":"Chiang","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"11","key":"B15","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.4049\/jimmunol.171.11.5940","article-title":"Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma","volume":"171","author":"Goldszmid","year":"2003","journal-title":"J Immunol"},{"issue":"7","key":"B16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/CJI.0b013e31818213df","article-title":"Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy","volume":"31","author":"Hatfield","year":"2008","journal-title":"J Immunother"},{"issue":"2","key":"B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.imlet.2005.10.021","article-title":"Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer","volume":"103","author":"Kim","year":"2006","journal-title":"Immunol Lett"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1083669","article-title":"Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma","author":"Vandenberk","year":"2015","journal-title":"Oncoimmunology"},{"issue":"22","key":"B19","first-page":"8105","article-title":"Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization","volume":"61","author":"Kotera","year":"2001","journal-title":"Cancer Res"},{"issue":"1","key":"B20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/cdd.2013.48","article-title":"Danger signalling during cancer cell death: origins, plasticity and regulation","volume":"21","author":"Garg","year":"2014","journal-title":"Cell Death Differ"},{"issue":"9","key":"B21","doi-asserted-by":"publisher","first-page":"e955691","DOI":"10.4161\/21624011.2014.955691","article-title":"Consensus guidelines for the detection of immunogenic cell death","volume":"3","author":"Kepp","year":"2014","journal-title":"Oncoimmunology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"B23","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/sj.cdd.4402201","article-title":"Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis","volume":"14","author":"Obeid","year":"2007","journal-title":"Cell Death Differ"},{"issue":"50","key":"B24","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1016\/j.vaccine.2008.08.063","article-title":"Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity","volume":"26","author":"Brusa","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"B25","doi-asserted-by":"publisher","first-page":"e1011492","DOI":"10.1080\/2162402X.2015.1011492","article-title":"Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen","volume":"4","author":"Creaney","year":"2015","journal-title":"Oncoimmunology"},{"issue":"12","key":"B26","first-page":"1396","article-title":"Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection","volume":"88","author":"Di Nicola","year":"2003","journal-title":"Haematologica"},{"issue":"13","key":"B27","first-page":"3542","article-title":"Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells","volume":"60","author":"Hoffmann","year":"2000","journal-title":"Cancer Res"},{"issue":"2","key":"B28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ Res"},{"issue":"4","key":"B29","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4049\/jimmunol.1003906","article-title":"Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress","volume":"187","author":"Moghaddam","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"B30","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/s00262-006-0127-9","article-title":"Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells","volume":"55","author":"Chiang","year":"2006","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"B31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2567.1998.00618.x","article-title":"Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells","volume":"95","author":"Carrasco-Marin","year":"1998","journal-title":"Immunology"},{"issue":"12","key":"B32","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1182\/blood-2002-05-1389","article-title":"Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells","volume":"100","author":"Feng","year":"2002","journal-title":"Blood"},{"issue":"12","key":"B33","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/pros.20981","article-title":"Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells","volume":"69","author":"Brusa","year":"2009","journal-title":"Prostate"},{"issue":"4","key":"B34","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.4049\/jimmunol.176.4.2134","article-title":"Hyperthermia enhances CTL cross-priming","volume":"176","author":"Shi","year":"2006","journal-title":"J Immunol"},{"issue":"16","key":"B35","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-12-0851","article-title":"Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma","volume":"72","author":"Suzuki","year":"2012","journal-title":"Cancer Res"},{"issue":"3","key":"B36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.radonc.2011.05.051","article-title":"Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment","volume":"99","author":"Stangl","year":"2011","journal-title":"Radiother Oncol"},{"issue":"1","key":"B37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4049\/jimmunol.174.1.90","article-title":"Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells","volume":"174","author":"Prasad","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"B38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4049\/jimmunol.1200563","article-title":"Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation","volume":"189","author":"Gupta","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"B39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clim.2007.02.005","article-title":"Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression","volume":"123","author":"Huang","year":"2007","journal-title":"Clin Immunol"},{"issue":"6","key":"B40","first-page":"1884","article-title":"Strategies for antigen loading of dendritic cells to enhance the antitumor immune response","volume":"62","author":"Strome","year":"2002","journal-title":"Cancer Res"},{"issue":"11","key":"B41","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-012-1258-9","article-title":"Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine","volume":"61","author":"Chen","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"B42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/ijc.28766","article-title":"High hydrostatic pressure induces immunogenic cell death in human tumor cells","volume":"135","author":"Fucikova","year":"2014","journal-title":"Int J Cancer"},{"issue":"9","key":"B43","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1158\/0008-5472.CAN-11-2975","article-title":"Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus","volume":"72","author":"Diaconu","year":"2012","journal-title":"Cancer Res"},{"issue":"10","key":"B44","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/0008-5472.CAN-11-3185","article-title":"Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma","volume":"72","author":"Miyamoto","year":"2012","journal-title":"Cancer Res"},{"issue":"5","key":"B45","doi-asserted-by":"publisher","first-page":"E313","DOI":"10.1002\/ijc.29202","article-title":"Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death","volume":"136","author":"Koks","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/gt.2011.205","article-title":"Measles virus causes immunogenic cell death in human melanoma","volume":"20","author":"Donnelly","year":"2013","journal-title":"Gene Ther"},{"issue":"4","key":"B47","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/ijo.21.4.685","article-title":"Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients","volume":"21","author":"Bai","year":"2002","journal-title":"Int J Oncol"},{"issue":"2","key":"B48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00262-011-1184-2","article-title":"Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin","volume":"61","author":"Garg","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"B49","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/emboj.2011.497","article-title":"A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death","volume":"31","author":"Garg","year":"2012","journal-title":"EMBO J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e826","DOI":"10.1038\/cddis.2013.372","article-title":"Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene. LAMP2A","volume":"4","author":"Garg","year":"2013","journal-title":"Cell Death Dis"},{"issue":"3","key":"B51","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/0008-5472.1018.65.3","article-title":"Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response","volume":"65","author":"Korbelik","year":"2005","journal-title":"Cancer Res"},{"issue":"10","key":"B52","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00262-011-1047-x","article-title":"Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release","volume":"60","author":"Korbelik","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"B53","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4161\/auto.25399","article-title":"ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death","volume":"9","author":"Garg","year":"2013","journal-title":"Autophagy"},{"issue":"10","key":"B54","doi-asserted-by":"publisher","first-page":"e26260","DOI":"10.4161\/onci.26260","article-title":"Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity","volume":"2","author":"Garg","year":"2013","journal-title":"Oncoimmunology"},{"issue":"6","key":"B55","first-page":"1604","article-title":"Generation of effective antitumor vaccines using photodynamic therapy","volume":"62","author":"Gollnick","year":"2002","journal-title":"Cancer Res"},{"issue":"8","key":"B56","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s00262-005-0088-4","article-title":"Photodynamic therapy-generated vaccine for cancer therapy","volume":"55","author":"Korbelik","year":"2006","journal-title":"Cancer Immunol Immunother"},{"issue":"22","key":"B57","doi-asserted-by":"publisher","first-page":"9062","DOI":"10.1158\/0008-5472.CAN-10-1825","article-title":"Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death","volume":"70","author":"Zappasodi","year":"2010","journal-title":"Cancer Res"},{"issue":"10","key":"B58","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1158\/1078-0432.CCR-07-4875","article-title":"Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme","volume":"14","author":"De Vleeschouwer","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"4","key":"B59","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pbc.22319","article-title":"Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours","volume":"54","author":"Ardon","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"B60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11060-010-0131-y","article-title":"Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study","volume":"99","author":"Ardon","year":"2010","journal-title":"J Neurooncol"},{"issue":"11","key":"B61","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00262-012-1261-1","article-title":"Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I\/II trial","volume":"61","author":"Ardon","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"B62","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00262-012-1271-z","article-title":"Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination","volume":"61","author":"De Vleeschouwer","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5402\/2012\/530179","article-title":"Resection and immunotherapy for recurrent grade III glioma","volume":"14","author":"Elens","year":"2012","journal-title":"Neuro Oncol"},{"issue":"4","key":"B64","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/CJI.0b013e318215e300","article-title":"Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy","volume":"34","author":"Fadul","year":"2011","journal-title":"J Immunother"},{"issue":"9","key":"B65","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/sj.bjc.6602195","article-title":"Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study","volume":"91","author":"Rutkowski","year":"2004","journal-title":"Br J Cancer"},{"issue":"11","key":"B66","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5306\/wjco.v3.i11.142","article-title":"Dendritic cell vaccination in glioblastoma after fluorescence-guided resection","volume":"3","author":"Valle","year":"2012","journal-title":"World J Clin Oncol"},{"issue":"1","key":"B67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12013-011-9265-6","article-title":"Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma","volume":"62","author":"Jie","year":"2012","journal-title":"Cell Biochem Biophys"},{"issue":"8","key":"B68","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1158\/1078-0432.CCR-10-2384","article-title":"Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells","volume":"17","author":"Aguilera","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5\u20136","key":"B69","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.wneu.2011.08.020","article-title":"Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial","volume":"77","author":"Cho","year":"2012","journal-title":"World Neurosurg"},{"issue":"2","key":"B70","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jocn.2007.08.007","article-title":"Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy","volume":"15","author":"Walker","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"12","key":"B71","doi-asserted-by":"publisher","first-page":"e968434","DOI":"10.4161\/21624011.2014.968434","article-title":"Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy","volume":"3","author":"Adkins","year":"2014","journal-title":"Oncoimmunology"},{"issue":"8","key":"B72","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol Ther"},{"issue":"7","key":"B73","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1172\/JCI45585","article-title":"Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice","volume":"121","author":"Woller","year":"2011","journal-title":"J Clin Invest"},{"issue":"8","key":"B74","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2217\/imt.15.48","article-title":"Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report","volume":"7","author":"Schirrmacher","year":"2015","journal-title":"Immunotherapy"},{"issue":"13","key":"B75","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1158\/1078-0432.CCR-04-0367","article-title":"Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells","volume":"10","author":"Jalili","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"B76","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med"},{"issue":"4","key":"B77","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1182\/blood-2009-11-251884","article-title":"Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells","volume":"116","author":"Schreibelt","year":"2010","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fimmu.2014.00165","article-title":"Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets","volume":"5","author":"Wimmers","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"B79","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-12-2583","article-title":"Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients","volume":"73","author":"Tel","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"B80","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4049\/jimmunol.1401607","article-title":"Dendritic cell-based vaccines that utilize myeloid rather than plasmacytoid cells offer a superior survival advantage in malignant glioma","volume":"195","author":"Dey","year":"2015","journal-title":"J Immunol"},{"issue":"9","key":"B81","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.4161\/hv.25373","article-title":"Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy","volume":"9","author":"Anguille","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"B82","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1158\/1078-0432.CCR-10-3421","article-title":"Peptide-loaded langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo","volume":"17","author":"Romano","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"B83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.0105-2896.2009.00884.x","article-title":"Harnessing human dendritic cell subsets for medicine","volume":"234","author":"Ueno","year":"2010","journal-title":"Immunol Rev"},{"issue":"5","key":"B84","doi-asserted-by":"publisher","first-page":"e0123340","DOI":"10.1371\/journal.pone.0123340","article-title":"Interleukin-15 dendritic cells harness NK cell cytotoxic effector function in a contact- and IL-15-dependent manner","volume":"10","author":"Anguille","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"B85","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/mt.2009.95","article-title":"Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"},{"issue":"10","key":"B86","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1634\/theoncologist.2011-0122","article-title":"NK cells: key to success of DC-based cancer vaccines?","volume":"17","author":"Lion","year":"2012","journal-title":"Oncologist"},{"issue":"11","key":"B87","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/neuonc\/nou212","article-title":"Immunotherapy advances for glioblastoma","volume":"16","author":"Reardon","year":"2014","journal-title":"Neuro Oncol"},{"issue":"11","key":"B88","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma cancer stem cells induce immunosuppressive macrophages\/microglia","volume":"12","author":"Wu","year":"2010","journal-title":"Neuro Oncol"},{"issue":"3","key":"B89","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","article-title":"Immunobiological characterization of cancer stem cells isolated from glioblastoma patients","volume":"16","author":"Di Tomaso","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"8","key":"B90","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/stem.102","article-title":"Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens","volume":"27","author":"Xu","year":"2009","journal-title":"Stem Cells"},{"issue":"21","key":"B91","doi-asserted-by":"publisher","first-page":"10247","DOI":"10.1158\/0008-5472.CAN-06-2048","article-title":"Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas","volume":"66","author":"Pellegatta","year":"2006","journal-title":"Cancer Res"},{"issue":"14","key":"B92","first-page":"5091","article-title":"Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients","volume":"9","author":"de Vries","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"4","key":"B93","doi-asserted-by":"publisher","first-page":"e18801","DOI":"10.1371\/journal.pone.0018801","article-title":"Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis","volume":"6","author":"Draube","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"B94","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1158\/1078-0432.CCR-05-0120","article-title":"Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I\/II trial","volume":"11","author":"Yamanaka","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"17","key":"B95","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1158\/1078-0432.CCR-11-1261","article-title":"Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients","volume":"17","author":"Lesterhuis","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"4","key":"B96","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1750-3639.2009.00316.x","article-title":"Dendritic cell therapy of high-grade gliomas","volume":"19","author":"Van Gool","year":"2009","journal-title":"Brain Pathol"},{"issue":"12","key":"B97","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"1997","journal-title":"Eur J Immunol"},{"issue":"Suppl 4","key":"B98","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1016\/S0264-410X(02)00382-1","article-title":"A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy","volume":"20","author":"Lee","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"B99","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1200\/JCO.2010.30.7744","article-title":"Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma","volume":"29","author":"Okada","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8","key":"B100","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1172\/JCI68395","article-title":"IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity","volume":"123","author":"Carreno","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"B101","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1189\/jlb.1107737","article-title":"Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia","volume":"84","author":"Lee","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"17","key":"B102","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-04-1261","article-title":"alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity","volume":"64","author":"Mailliard","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"B103","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/01.cji.0000211309.90621.8b","article-title":"Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity","volume":"29","author":"Palucka","year":"2006","journal-title":"J Immunother"},{"issue":"5","key":"B104","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.smim.2008.09.006","article-title":"Antigens for cancer immunotherapy","volume":"20","author":"Neller","year":"2008","journal-title":"Semin Immunol"},{"issue":"2","key":"B105","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CJI.0b013e3182811ae4","article-title":"Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients","volume":"36","author":"Prins","year":"2013","journal-title":"J Immunother"},{"issue":"2","key":"B106","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0008-8749(91)90159-9","article-title":"Ultraviolet light-induced increase in tumor cell susceptibility to TNF-dependent and TNF-independent natural cell-mediated cytotoxicity","volume":"138","author":"Begovic","year":"1991","journal-title":"Cell Immunol"},{"issue":"4\u20135","key":"B107","first-page":"250","article-title":"Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis","volume":"12","author":"Begovic","year":"1993","journal-title":"Nat Immun"},{"issue":"17","key":"B108","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1158\/1078-0432.CCR-13-0398","article-title":"BRAF\/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage","volume":"19","author":"Mar","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"5","key":"B109","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1172\/JCI25591","article-title":"Optimization of a self antigen for presentation of multiple epitopes in cancer immunity","volume":"116","author":"Guevara-Patino","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"B110","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/09553009014552221","article-title":"Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load","volume":"58","author":"Harmon","year":"1990","journal-title":"Int J Radiat Biol"},{"issue":"12","key":"B111","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"B112","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cytogfr.2013.01.005","article-title":"Inducers of immunogenic cancer cell death","volume":"24","author":"Dudek","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B113","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fimmu.2015.00588","article-title":"Molecular and translational classifications of DAMPs in immunogenic cell death","volume":"6","author":"Garg","year":"2015","journal-title":"Front Immunol"},{"issue":"3\u20134","key":"B114","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10354-012-0052-9","article-title":"Basic principles of molecular effects of irradiation","volume":"162","author":"Selzer","year":"2012","journal-title":"Wien Med Wochenschr"},{"issue":"3","key":"B115","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"B116","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.seminoncol.2012.02.006","article-title":"The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors","volume":"39","author":"Hodge","year":"2012","journal-title":"Semin Oncol"},{"issue":"1","key":"B117","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1182\/blood-2008-06-165654","article-title":"Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study","volume":"113","author":"Di Nicola","year":"2009","journal-title":"Blood"},{"issue":"10","key":"B118","first-page":"598","article-title":"[Clinical trial on the effects of shikonin mixture on later stage lung cancer]","volume":"11","author":"Guo","year":"1991","journal-title":"Zhong Xi Yi Jie He Za Zhi"},{"issue":"12","key":"B119","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1055\/s-2003-45193","article-title":"Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin","volume":"69","author":"Chen","year":"2003","journal-title":"Planta Med"},{"issue":"10","key":"B120","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/ijc.24195","article-title":"Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo","volume":"124","author":"Yang","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"B121","first-page":"459","article-title":"Hydrostatic pressure induced death of mammalian cells engages pathways related to apoptosis or necrosis","volume":"50","author":"Frey","year":"2004","journal-title":"Cell Mol Biol"},{"issue":"23","key":"B122","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.2174\/092986708785909166","article-title":"Cells under pressure \u2013 treatment of eukaryotic cells with high hydrostatic pressure, from physiologic aspects to pressure induced cell death","volume":"15","author":"Frey","year":"2008","journal-title":"Curr Med Chem"},{"issue":"4","key":"B123","first-page":"469","article-title":"High hydrostatic pressure inactivated human tumour cells preserve their immunogenicity","volume":"50","author":"Korn","year":"2004","journal-title":"Cell Mol Biol"},{"issue":"4","key":"B124","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1464-410X.1972.tb10103.x","article-title":"Treatment of bladder carcinoma by a hydrostatic pressure technique. Report on 43 cases","volume":"44","author":"Helmstein","year":"1972","journal-title":"Br J Urol"},{"issue":"5","key":"B125","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF01741168","article-title":"Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking","volume":"36","author":"Eisenthal","year":"1993","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"B126","first-page":"350","article-title":"Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine","volume":"60","author":"Goldman","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"B127","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/15476911003657414","article-title":"High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features","volume":"7","author":"Weiss","year":"2010","journal-title":"J Immunotoxicol"},{"issue":"3","key":"B128","doi-asserted-by":"publisher","first-page":"203","DOI":"10.7150\/jca.10640","article-title":"Immune suppression during oncolytic virotherapy for high-grade glioma. Yes or No?","volume":"6","author":"Koks","year":"2015","journal-title":"J Cancer"},{"issue":"4","key":"B129","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"B130","doi-asserted-by":"publisher","first-page":"e34475","DOI":"10.1371\/journal.pone.0034475","article-title":"In vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cells","volume":"7","author":"Garg","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"B131","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s10495-010-0479-7","article-title":"Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity","volume":"15","author":"Garg","year":"2010","journal-title":"Apoptosis"},{"issue":"3","key":"B132","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1039\/c3pp50333j","article-title":"ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses","volume":"13","author":"Garg","year":"2014","journal-title":"Photochem Photobiol Sci"},{"issue":"7","key":"B133","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/bjc.2011.327","article-title":"Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro","volume":"105","author":"Etminan","year":"2011","journal-title":"Br J Cancer"},{"issue":"7","key":"B134","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/lsm.21108","article-title":"Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70","volume":"43","author":"Mitra","year":"2011","journal-title":"Lasers Surg Med"},{"issue":"8","key":"B135","doi-asserted-by":"publisher","first-page":"e105778","DOI":"10.1371\/journal.pone.0105778","article-title":"Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of damage-associated molecular patterns (DAMPs) in human HeLa cells","volume":"9","author":"Panzarini","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"B136","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/cdd.2012.74","article-title":"PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress","volume":"19","author":"Verfaillie","year":"2012","journal-title":"Cell Death Differ"},{"issue":"4","key":"B137","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.pdpdt.2011.04.003","article-title":"Low dose hypericin-PDT induces complete tumor regression in BALB\/c mice bearing CT26 colon carcinoma","volume":"8","author":"Sanovic","year":"2011","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"B138","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2012.04.024","article-title":"Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors","volume":"324","author":"Jung","year":"2012","journal-title":"Cancer Lett"},{"issue":"14","key":"B139","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1158\/0008-5472.CAN-07-5973","article-title":"Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients","volume":"68","author":"Wheeler","year":"2008","journal-title":"Cancer Res"},{"issue":"19","key":"B140","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-09-1254","article-title":"Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma","volume":"15","author":"Ribas","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fimmu.2015.00271","article-title":"Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy","volume":"6","author":"Datta","year":"2015","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T13:43:39Z","timestamp":1692193419000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2015.00663\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":141,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2015.00663","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}